Questions discussed in this category
Individual times in the therapeutic range while on VKA treatment was not registered in FRAIL-AF.
In what clinical scenarios do you utilize post-cardiac arrest targeted temperature management (TTM)?
In the span between the HACA trial and the Targeted Temperature Management in Out-of-Hospital Cardiac Arrest study (Dankiewicz et al., PMID 34133859),...
In FRAIL-AF, switching VKA therapy to a NOAC was associated with higher risk of bleeding in elderly, frail patients.
In FRAIL-AF, participants were switched from VKA to dabigatran, rivaroxaban, apixaban, and edoxaban.
Papers discussed in this category
The New England journal of medicine, 2002-02-21
N Engl J Med, 2013 Nov 17
Cureus, 2022 Sep 11
Crit Care, 2020 Jan 06
Circulation, 2023 Aug 27